
Board Meeting13 Aug 2026, 05:03 pm
Natraj Proteins Board Approves Unaudited Q1 FY27 Results
AI Summary
Natraj Proteins Ltd announced the outcome of its Board of Directors meeting held on August 13, 2026. The board considered and approved the unaudited financial results for the quarter ended June 30, 2026. Additionally, the re-appointment of Shri Sharad Kumar Jain as Whole Time Director for a further period of 3 years effective October 1, 2026, was recommended. The board also approved the appointment of a scrutinizer for e-voting and M/s Yogesh Chourasia and Associates as Cost Auditor for FY 2026-27. The Limited Review Report from the statutory auditors on the unaudited financial results was also taken on record.
Key Highlights
- Board approved unaudited financial results for Q1 FY27.
- Recommended re-appointment of Whole Time Director for 3 years.
- Approved appointment of Cost Auditor for FY 2026-27.
- Statutory auditors' limited review report taken on record.
Price Impact
More from NATRAJPR